Rituximab treatment for refractory steroid-resistant nephrotic syndrome

Pediatr Nephrol. 2016 Feb;31(2):337-8. doi: 10.1007/s00467-015-3205-4. Epub 2015 Sep 19.

Authors

Koichi Kamei¹, Kenji Ishikura²

Affiliations

¹ Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. kamei-k@ncchd.go.jp.
² Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

PMID: 26386588
DOI: 10.1007/s00467-015-3205-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Immunologic Factors / pharmacokinetics*
Male
Nephrotic Syndrome / drug therapy*
Rituximab / pharmacokinetics*

Substances

Immunologic Factors
Rituximab